دورية أكاديمية
Barriers to early diagnosis of cervical cancer: a mixed-method study in Côte d'Ivoire, West Africa.
| العنوان: | Barriers to early diagnosis of cervical cancer: a mixed-method study in Côte d'Ivoire, West Africa. |
|---|---|
| المؤلفون: | Plaisy MK; Research Institute for Sustainable Development (IRD) EMR 271, University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Bordeaux Population Health Centre, Bordeaux, France. marie-kerbie.plaisy@u-bordeaux.fr., Boni SP; National Cancer Control Program, Abidjan, Côte d'Ivoire., Coffie PA; PACCI Program, National Agency for Scientific Research (ANRS) site in Côte d'Ivoire, Abidjan, Côte d'Ivoire., Tanon A; Tropical and Infectious Diseases Department, University Hospital of Treichville, Abidjan, Côte d'Ivoire., Innocent A; Oncology Department, University Hospital of Treichville, Abidjan, Côte d'Ivoire., Horo A; Gyneco-Obstetrics Department, University Hospital of Yopougon, Abidjan, Côte d'Ivoire., Dabis F; Research Institute for Sustainable Development (IRD) EMR 271, University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Bordeaux Population Health Centre, Bordeaux, France., Bekelynck A; PACCI Program, National Agency for Scientific Research (ANRS) site in Côte d'Ivoire, Abidjan, Côte d'Ivoire., Jaquet A; Research Institute for Sustainable Development (IRD) EMR 271, University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Bordeaux Population Health Centre, Bordeaux, France. |
| مؤلفون مشاركون: | IeDEA West Africa Collaboration |
| المصدر: | BMC women's health [BMC Womens Health] 2023 Mar 27; Vol. 23 (1), pp. 135. Date of Electronic Publication: 2023 Mar 27. |
| نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101088690 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6874 (Electronic) Linking ISSN: 14726874 NLM ISO Abbreviation: BMC Womens Health Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [London] : BioMed Central, 2001- |
| مواضيع طبية MeSH: | Uterine Cervical Neoplasms*/diagnosis , Uterine Cervical Neoplasms*/prevention & control , Delayed Diagnosis*, Female ; Humans ; Middle Aged ; Cote d'Ivoire/epidemiology ; Cross-Sectional Studies ; Early Detection of Cancer ; HIV Infections/prevention & control ; Health Knowledge, Attitudes, Practice ; Insurance, Health |
| مستخلص: | Background: Cervical cancer, a major public health problem in many developing countries, is usually associated with a poor survival related to an advanced disease at diagnosis. In Côte d'Ivoire and other developing countries with high cervical cancer prevalence, little is known about factors associated with advanced cervical cancer stages in a context of limited access to screening services. Methods: From May to July 2019, we conducted a cross-sectional study using a mixed, quantitative and qualitative method. Information on socio-demographic and history of the disease was extracted from a rapid case ascertainement study performed by the cancer registry of Côte d'Ivoire that enrolled all women diagnosed with cervical cancer between July 2018 and June 2019. In-depth semi-structured interviews were conducted among a subset of these women (12 women) and six healthcare providers to further capture barriers to early cervical cancer diagnosis. Factors associated with an advanced stage III, IV (according to FIGO classification) were estimated by a logistic regression model. Qualitative data were analyzed using a thematic analysis technique guided by the treatment pathway model and triangulated with quantitative data. Results: In total, 95 women with cervical cancer [median age = 51 (IQR 42-59)] years, were included. Among them, 18.9% were living with HIV and only 9.5% were covered by a health insurance. The majority (71.5%) were diagnosed with advanced cervical cancer. Being HIV-uninfected (aOR = 5.4; [1.6-17.8], p = 0.006) and being uninsured (aOR = 13.1; [2.0-85.5], p = 0.007) were independently associated with advanced cervical cancer in multivariable analysis. Qualitative data raised additional factors potentially related to advanced cervical cancer stages at diagnosis, including the lack of patient information on cervical cancer by healthcare providers and inadequate national awareness and screening campaigns. Conclusion: In a context of challenges in access to systematic cervical cancer screening in Côte d'Ivoire, access to health insurance or integrated healthcare program appear to be key determinants of early diagnosis of cervical cancer. (© 2023. The Author(s).) |
| References: | Thorax. 2018 Dec;73(12):1128-1136. (PMID: 29950525) Cancer Manag Res. 2021 Jan 22;13:579-585. (PMID: 33519237) PLoS One. 2012;7(10):e48108. (PMID: 23144732) Int J Womens Health. 2011;3:385-9. (PMID: 22140326) Lancet. 2019 Jan 12;393(10167):169-182. (PMID: 30638582) Asian Pac J Cancer Prev. 2015;16(2):635-9. (PMID: 25684499) Br J Cancer. 2013 Feb 19;108(3):686-90. (PMID: 23392082) BMC Public Health. 2020 Feb 27;20(1):274. (PMID: 32106837) Int J Gynaecol Obstet. 2019 Apr;145(1):129-135. (PMID: 30656645) BMJ Open. 2016 Jan 21;6(1):e007690. (PMID: 26801459) Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. (PMID: 23199955) J Health Serv Res Policy. 2010 Apr;15(2):123-5. (PMID: 19762883) Prev Chronic Dis. 2012;9:E93. (PMID: 22554408) Ann Oncol. 2007 Jul;18(7):1172-6. (PMID: 17434897) Br J Cancer. 2014 Aug 26;111(5):965-9. (PMID: 24992581) Pan Afr Med J. 2014 Jul 05;18:202. (PMID: 25419329) Indian J Cancer. 2018 Jan-Mar;55(1):45-49. (PMID: 30147092) CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338) Br J Health Psychol. 2013 Feb;18(1):45-65. (PMID: 22536840) Syst Rev. 2013 May 24;2:35. (PMID: 23706117) J Health Serv Res Policy. 2012 Apr;17(2):110-8. (PMID: 22008712) Health Promot Int. 2021 Dec 23;36(6):1656-1671. (PMID: 33647930) Healthcare (Basel). 2022 Aug 24;10(9):. (PMID: 36141217) J Natl Cancer Inst. 2020 Jul 1;112(7):671-687. (PMID: 32337585) BMC Womens Health. 2016 Jan 25;16:5. (PMID: 26809986) J Glob Oncol. 2018 Sep;4:1-9. (PMID: 30241147) BMC Womens Health. 2022 May 28;22(1):195. (PMID: 35643491) BMC Med Res Methodol. 2007 Jul 31;7:36. (PMID: 17663796) Int J Gynaecol Obstet. 2019 Nov;147(2):246-251. (PMID: 31482577) Papillomavirus Res. 2019 Dec;8:100170. (PMID: 31176807) Diagnostics (Basel). 2022 Nov 13;12(11):. (PMID: 36428831) BMC Public Health. 2018 Oct 3;18(1):1156. (PMID: 30285699) Am J Prev Med. 2021 Jan;60(1):104-109. (PMID: 33191064) South Med J. 2015 May;108(5):258-61. (PMID: 25972210) Trop Med Int Health. 2012 Dec;17(12):1426-31. (PMID: 23113824) J Epidemiol Community Health. 2001 Nov;55(11):782-8. (PMID: 11604432) Asian Pac J Cancer Prev. 2013;14(7):4373-7. (PMID: 23992006) |
| معلومات مُعتمدة: | U01 AI069919 United States AI NIAID NIH HHS |
| فهرسة مساهمة: | Keywords: Advanced cervical cancer stages; Andersen model; Cervical cancer; Côte d’Ivoire; Limited resources; Mixed methods study |
| تواريخ الأحداث: | Date Created: 20230327 Date Completed: 20230405 Latest Revision: 20230701 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10044424 |
| DOI: | 10.1186/s12905-023-02264-9 |
| PMID: | 36973736 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1472-6874 |
|---|---|
| DOI: | 10.1186/s12905-023-02264-9 |